Archive — page 2

A payment product touches product, risk, compliance, and technology. The decision belongs, by charter, to none of them.

A company can have a disciplined operating cadence at the top and still leave every team underneath it to coordinate however it happens to that week. The team is where the cost actually lands.

Fast growth financed by outside capital and slower growth financed by its own margin look similar on a revenue chart. They are not the same company three years later.

A business review and a diagnostic answer different questions. Skipping the review is what makes hiring consultants slower and more expensive than it should be.

A meeting that keeps not-quite-closing is not short of information. It is running on the wrong decision rule.

A weekly, a monthly, and a quarterly review are not the same meeting at three speeds. Each tier is built for a different class of change, and most operating cadences never draw that line.

The bill for growth bought without a differentiation budget does not land on this year's income statement. It lands three years later, in a competitor's pricing power.

The term gets used loosely enough that it has stopped meaning anything specific. It has one job: to describe the business accurately before anyone is paid to change it.

A decision can be final in the room and still unsettled everywhere the room cannot reach.

Most cadences are built by asking how often to meet. A cadence that survives the company changing size is built from decision rights instead, and the calendar comes after.

The top line can keep climbing for several quarters after the unit underneath it has already stopped paying for itself. The lag is the dangerous part.

The named problem is one observation about the business, not the finding. Diagnosis is the discipline of not stopping there.